UAE becomes first country to approve new GSK’s Sotrovimab drug for emergency treatment of coronavirus
London, May 30, 2021 (AltAfrica)-The United Arab Emirate UAE has approved GSK’s Sotrovimab COVID-19 drug emergency treatment of coronavirus making the UAE the first country in the world to approve the drug for emergency use following FDA approval
Emirates News Agency WAM reports that the drug Sotrovimab-VIR-7831, will contribute to reducing the number of cases requiring admission to hospital for more than 24 hours and reduce the number of deaths due to infection with the virus by up to 85 percent when given to patients as an early treatment.
Curious about how monoclonal antibodies (mAbs) can help us end the #pandemic? mAbs directly fight infection without waiting for our immune systems to respond to the virus. #mAbAwareness pic.twitter.com/Yk3dDOR15Z— GSK (@GSK) May 29, 2021
The UAE granted the emergency use of the drug which uses “monoclonal antibodies” to treat patients aged 12 years and over who face a high risk of developing severe symptoms and hospitalization due to the repercussions of the disease.
The approval of a new drug that studies have proven effective in treating the mutated virus and the emerging mutations from it and helps in speeding up the healing of the infected and reducing deaths among COVID-19 patients represents a positive development in the ongoing battle against the virus.
The approval of the drug in conjunction with the progress made by the UAE in providing vaccines and treatment will significantly increase the number of cures and decrease the death rate.